Light-Chain (AL) Cardiac Amyloidosis Presenting as Heart Failure With Reduced Ejection Fraction

被引:0
|
作者
Santiago, Luis E. [1 ,2 ]
Alvi, Ali Tariq [1 ,2 ]
Melnychuk, Veniamin [1 ,2 ]
Mesquita, Philip [1 ,2 ]
Aneja, Pallavi [1 ,2 ]
机构
[1] HCA Florida Northwest Hosp, Internal Med, Margate, FL 33324 USA
[2] HCA Florida Westside Hosp, Internal Med, Plantation, FL 33324 USA
关键词
ttr cardiac amyloidosis; cardiac amyloidosis with reduced ejection fraction; diastolic heart failure; cardiac amyloidosis; immunoglobulin light-chain amyloidosis; DIAGNOSIS;
D O I
10.7759/cureus.55271
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Systemic amyloidosis is caused by the extracellular deposition of misfolded proteins in various organs and usually leads to organ dysfunction. The two common subtypes include light -chain amyloidosis and transthyretin amyloidosis. Deposition of these proteins in the heart can lead to infiltrative and restrictive cardiomyopathy, commonly manifesting as heart failure with preserved ejection fraction. However, systolic heart failure with reduced ejection fraction is mainly seen in the advanced stages of the disease. Here, we present the case of a 53 -year -old female who presented with new -onset heart failure with reduced ejection fraction with no prior symptoms or diagnosis of amyloidosis and diastolic dysfunction.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] STRAIN IMAGING IN LIGHT-CHAIN AMYLOIDOSIS WITH HEART FAILURE AND PRESERVED EJECTION FRACTION
    Barros-Gomes, Sergio
    Miller, Fletcher
    Pellikka, Patricia
    Dispenzieri, Angela
    Villarraga, Hector
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 887 - 887
  • [2] Therapeutic Strategy for Heart Failure with Reduced Ejection Fraction and Cardiac Amyloidosis
    Imamura, Teruhiko
    Izumida, Toshihide
    Nakamura, Makiko
    Kinugawa, Koichiro
    [J]. INTERNATIONAL HEART JOURNAL, 2022, 63 (02) : 408 - 410
  • [3] Systemic light-chain amyloidosis presenting with rapidly progressive heart failure
    Sunbul, M.
    Durmus, E.
    Kivrak, T.
    Besiroglu, F.
    Gerin, F.
    Sari, I.
    Mutlu, B.
    Hunuk, B.
    [J]. EUROPEAN HEART JOURNAL, 2013, 34 : 1133 - 1133
  • [4] Diagnosing heart failure with preserved ejection fraction in cardiac amyloidosis or diagnosing cardiac amyloidosis in heart failure with preserved ejection fraction?
    Lund, Lars H.
    Eldhagen, Per
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (12) : 2387 - 2389
  • [5] An Unusual Heart Failure Cardiac Amyloidosis Due to Light-Chain Myeloma
    Martinelli, Nicola
    Carleo, Pietro
    Girelli, Domenico
    Olivieri, Oliviero
    [J]. CIRCULATION, 2011, 123 (18) : E583 - E584
  • [6] Efficacy of Chemotherapy for Light-Chain Amyloidosis in Patients Presenting With Symptomatic Heart Failure
    Sperry, Brett W.
    Ikram, Asad
    Hachamovitch, Rory
    Valent, Jason
    Vranian, Michael N.
    Phelan, Dermot
    Hanna, Mazen
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (25) : 2941 - 2948
  • [7] High prevalence of heart failure with reduced ejection fraction in patients with transthyretin cardiac amyloidosis
    Talal Asif
    Tiago Araujo
    Vasvi Singh
    Saurabh Malhotra
    [J]. Journal of Nuclear Cardiology, 2020, 27 : 1044 - 1046
  • [8] High prevalence of heart failure with reduced ejection fraction in patients with transthyretin cardiac amyloidosis
    Asif, Talal
    Araujo, Tiago
    Singh, Vasvi
    Malhotra, Saurabh
    [J]. JOURNAL OF NUCLEAR CARDIOLOGY, 2020, 27 (03) : 1044 - 1046
  • [9] A Case of AL Amyloidosis in a Young Patient with Congestive Heart Failure with Reduced Ejection Fraction
    Van, E.
    Hanewich, M.
    Stewart, P.
    Akbarullah, S.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [10] Light-chain cardiac amyloidosis
    Mankad, Anit K.
    Sesay, Isata
    Shah, Keyur B.
    [J]. CURRENT PROBLEMS IN CANCER, 2017, 41 (02) : 144 - 156